• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素治疗流涎症的一种罕见并发症。

An unusual complication of Botox treatment for sialorrhoea.

作者信息

Layton Thomas Benjamin

机构信息

University of Manchester, United Kingdom.

出版信息

Int J Surg Case Rep. 2014;5(12):1072-3. doi: 10.1016/j.ijscr.2014.10.072. Epub 2014 Nov 4.

DOI:10.1016/j.ijscr.2014.10.072
PMID:25460477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4275974/
Abstract

INTRODUCTION

To illustrate the potential side effects and clinical efficacy of Botox injections in treating sialorrhoea.

PRESENTATION OF CASE

A 26-year-old patient with cerebral palsy with dystonia had a long history of severe, distressing sialorrhoea. She was treated with three separate Botox injections into her salivary glands in December 2011, July 2012 and March 2013.

DISCUSSION

Following the Botox injections the patient developed dysphagia, began to expectorate thick mucus and developed a cough; she was treated for a chest injection and during this time her feeding deteriorated. Three injections were given as the patient had an objective and significant reduction in salivation. However, the side effect profile was deemed too great to continue with treatment.

CONCLUSION

Botox is a novel and effective treatment for reducing saliva production. Its clinical efficacy is supported by this case and correlates with the recent literature. Although rare, significant side effects can happen and the case presented illustrates the care needed when administering injections, particularly in a subgroup of patients.

摘要

引言

阐述肉毒杆菌毒素注射治疗流涎症的潜在副作用及临床疗效。

病例介绍

一名26岁患有肌张力障碍的脑瘫患者,有严重且令人苦恼的流涎症病史已久。她于2011年12月、2012年7月和2013年3月分别接受了三次肉毒杆菌毒素注射到唾液腺。

讨论

肉毒杆菌毒素注射后,患者出现吞咽困难,开始咳出浓稠黏液并出现咳嗽;她因胸部感染接受治疗,在此期间其进食情况变差。因患者流涎客观且显著减少,所以进行了三次注射。然而,副作用被认为太大,无法继续治疗。

结论

肉毒杆菌毒素是一种减少唾液分泌的新型有效治疗方法。该病例支持其临床疗效,且与近期文献相符。虽然罕见,但可能发生严重副作用,本病例表明注射时需要谨慎,尤其是在特定患者亚组中。

相似文献

1
An unusual complication of Botox treatment for sialorrhoea.肉毒杆菌毒素治疗流涎症的一种罕见并发症。
Int J Surg Case Rep. 2014;5(12):1072-3. doi: 10.1016/j.ijscr.2014.10.072. Epub 2014 Nov 4.
2
Botulinum toxin type-A (Botox-A) injections for treatment of sialorrhoea in adults: a New Zealand study.用于治疗成人流涎症的A型肉毒杆菌毒素(保妥适)注射:一项新西兰的研究。
N Z Med J. 2006 Aug 18;119(1240):U2129.
3
Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.肉毒毒素 A 治疗与神经障碍相关的流涎症:评估治疗效果与治疗腺体数量之间的关系。
Toxins (Basel). 2018 Jan 27;10(2):55. doi: 10.3390/toxins10020055.
4
Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.管理流涎(流口水)儿童:来自我们唾液控制诊所前301名儿童的经验。
Int J Pediatr Otorhinolaryngol. 2016 Jun;85:33-9. doi: 10.1016/j.ijporl.2016.03.010. Epub 2016 Mar 19.
5
[Submandibular gland resection for the management of sialorrhea in paediatric patients with cerebral palsy and unresponsive to type A botullinum toxin. Pilot study].[下颌下腺切除术治疗对A型肉毒毒素无反应的小儿脑性瘫痪流涎症。初步研究]
Cir Cir. 2016 Nov-Dec;84(6):459-468. doi: 10.1016/j.circir.2016.03.007. Epub 2016 May 21.
6
Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders.超声引导下A型肉毒杆菌毒素注射治疗神经疾病患者的流涎症
J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):538-40. doi: 10.1136/jnnp.70.4.538.
7
Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.肉毒杆菌毒素治疗肌萎缩侧索硬化症流涎后延髓功能急性恶化
Am J Phys Med Rehabil. 2008 Apr;87(4):321-4. doi: 10.1097/PHM.0b013e318164a931.
8
Ten years of experience with intravesical and intrasphincteric onabotulinumtoxinA in children.儿童膀胱内及括约肌内注射A型肉毒杆菌毒素的十年经验
J Pediatr Urol. 2016 Apr;12(2):94.e1-6. doi: 10.1016/j.jpurol.2015.06.019. Epub 2015 Oct 21.
9
Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.肉毒杆菌毒素注射治疗儿童慢性流涎症有效,与神经功能障碍程度无关:一所三级医疗机构的经验
Int J Pediatr Otorhinolaryngol. 2016 Sep;88:142-5. doi: 10.1016/j.ijporl.2016.06.031. Epub 2016 Jun 11.
10
Therapeutic Plasma Exchange in a rare case myasthenic crisis after Botox injection.肉毒杆菌毒素注射后罕见的重症肌无力危象中的治疗性血浆置换
Atheroscler Suppl. 2017 Nov;30:283-285. doi: 10.1016/j.atherosclerosissup.2017.05.016. Epub 2017 May 31.

本文引用的文献

1
Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.流涎症:解剖学、病理生理学和治疗,重点介绍肉毒毒素的作用。
Toxins (Basel). 2013 May 21;5(5):1010-31. doi: 10.3390/toxins5051010.
2
Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.肉毒毒素 A 长期安全性和疗效数据:一种用于流涎的注射剂。
JAMA Otolaryngol Head Neck Surg. 2013 Feb;139(2):134-8. doi: 10.1001/jamaoto.2013.1328.
3
Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.肉毒杆菌毒素(®)治疗神经功能障碍的儿科患者流涎:一项 I 期研究。
Int J Lang Commun Disord. 2011 Sep-Oct;46(5):550-63. doi: 10.1111/j.1460-6984.2011.00010.x. Epub 2011 Mar 7.
4
Salivary gland application of botulinum toxin for the treatment of sialorrhea.肉毒杆菌毒素在唾液腺的应用治疗流涎症。
Med Oral Patol Oral Cir Bucal. 2007 Nov 1;12(7):E511-7.
5
Clinical assessment of dysphagia in early phases of Parkinson's disease.帕金森病早期吞咽困难的临床评估
Neurol Sci. 2002 Sep;23 Suppl 2:S121-2. doi: 10.1007/s100720200099.
6
Treatment of relative sialorrhoea with botulinum toxin type A: description and rationale for an injection procedure with case report.
Eur J Neurol. 2001 Nov;8(6):567-71. doi: 10.1046/j.1468-1331.2001.00328.x.
7
Botulinum toxin A as treatment for drooling saliva in PD.肉毒杆菌毒素A治疗帕金森病流涎症
Neurology. 2000 Jan 11;54(1):244-7. doi: 10.1212/wnl.54.1.244.
8
Cranial nerve modulation of human cortical swallowing motor pathways.人类皮质吞咽运动通路的脑神经调制
Am J Physiol. 1997 Apr;272(4 Pt 1):G802-8. doi: 10.1152/ajpgi.1997.272.4.G802.